Is Trogocytosis a Predictive Marker of CAR-T Cell Response in Diffuse Large B-cell Lymphoma?

NCT06352242 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

85

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma

Interventions

OTHER: Flow cytometry analysis to determine the level of trogocytosis by effector immune cells in patients
OTHER: Flow cytometry analysis to determine the level of trogocytosis by effector immune cells in volunteers

Sponsor

University Hospital, Montpellier